Company Overview of Modra Pharmaceuticals B.V.
Modra Pharmaceuticals B.V., a clinical-stage company, designs and develops oral formulations of commonly used anti-cancer drugs that are available in intravenous (IV) forms. It offers Docetaxel and Paclitaxel that are anticancer drugs and members of the taxane class of chemotherapeutics are part of the treatment practices for various cancer indications. The company was founded in 2010 and is based in Amsterdam, the Netherlands.
Amsterdam, 1066 EC
Founded in 2010
31 20 512 4734
Key Executives for Modra Pharmaceuticals B.V.
Modra Pharmaceuticals B.V. Key Developments
Similar Private Companies By Industry
|Allgen Pharmaceuticals & Generics B.V.||Europe|
|Alzheimer Research Centrum BV||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Modra Pharmaceuticals B.V., please visit www.modrapharmaceuticals.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.